16h00 – 16h15Review of key safety resultsBernard Fourie
16h15 – 17h30DiscussionAll
17h30 – 18h00Recap and Key pointsHolger Schünemann
18h00End Day 1

From: Annex 3, Expert Group meeting on interim guidance for the use of delamanid in the treatment of multidrug-resistant tuberculosis

Cover of The Use of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis
The Use of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis: Interim Policy Guidance.
Copyright © World Health Organization 2014.

All rights reserved. Publications of the World Health Organization are available on the WHO website (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: tni.ohw@sredrokoob).

Requests for permission to reproduce or translate WHO publications –whether for sale or for non-commercial distribution– should be addressed to WHO Press through the WHO website (www.who.int/about/licensing/copyright_form/en/index.html).

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.